"Students for Life Action, which opposes abortion, in a statement Thursday called the approval "a stain on the Trump presidency and another sign that the deep state at the FDA must go." Republican Sen. Josh Hawley of Missouri also criticized the move in a post on X, stating, "I have lost confidence in the leadership at FDA." A spokesperson for the agency said the FDA "has very limited discretion in deciding whether to approve a generic drug," and added that FDA officials do not "endorse any product.""
"The criticism comes as Republican President Donald Trump's top health officials, including Health Secretary Robert F. Kennedy Jr., face growing pressure from abortion opponents to reevaluate mifepristone, which was approved 25 years ago and has repeatedly been deemed safe and effective by FDA scientists. In a letter to Republican attorneys general last month, Kennedy and FDA Commissioner Dr. Marty Makary pledged to conduct a full review of the drug's safety."
Federal regulators approved another generic version of the abortion pill mifepristone, authorized for terminating pregnancies through 10 weeks. The low-cost generic from Evita Solutions generated prompt backlash from anti-abortion groups and some Republican politicians who criticized FDA leadership. Agency spokespeople emphasized limited discretion in generic approvals and clarified that officials do not endorse products. Top health officials in the Trump administration, including Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary, pledged a full safety review of mifepristone amid pressure from opponents. The FDA previously approved the original drug in 2000 and the first generic in 2019, and permitted online prescribing in 2021.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]